Search Result "apoA-IM mutant"
ApoA-I Milano/phospholipid Complexes Emerging Pharmacological Strategies and Medications for the Prevention of Atherosclerotic Plaque Progression
Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 5 Issue: 6 Year: 2005 Page: 471-479
Author(s): Sanjay Kaul, Prediman K. Shah
Pharmacological Activation of LXRs Decreases Amyloid-β Levels in Niemann-Pick Type C Model Cells
Journal: Current Pharmaceutical Biotechnology
Volume: 14 Issue: 6 Year: 2013 Page: 582-593
Author(s): Jasminka Stefulj,Maja Peric,Martina Malnar,Marko Kosicek,Cornelia Schweinzer,Jelena Zivkovic,Monika Scholler,Ute Panzenboeck,Silva Hecimovic
Exploring the Influence of Mutation on Transthyretin Aggregation in Heart Disease
Journal: Current Computer-Aided Drug Design
Volume: 14 Issue: 2 Year: 2018 Page: 125-130
Author(s): Ankita Sharma,Monu,Sagarika Biswas
Biochemical Strategies to Anticoagulation: A Comparative Overview
Journal: Current Vascular Pharmacology
Volume: 2 Issue: 3 Year: 2004 Page: 199-228
Author(s): Arthur J. Chu
HDL Dysfunction Caused by Mutations in apoA-I and Other Genes that are Critical for HDL Biogenesis and Remodeling
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1544-1575
Author(s): Angeliki Chroni,Dimitris Kardassis
Metabolism of HDL and its Regulation
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 25 Year: 2014 Page: 2864-2880
Author(s): D. Kardassis,I. Mosialou,M. Kanaki,I. Tiniakou,E. Thymiakou
Recent Advances in the Mechanisms of Action and Physiological Functions of the Retinoid-Related Orphan Receptors (RORs)
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 3 Issue: 4 Year: 2004 Page: 395-412
Author(s): Anton M. Jetten
New Approaches in the Diagnosis of Atherosclerosis and Treatment of Cardiovascular Disease
Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 3 Issue: 2 Year: 2008 Page: 84-91
Author(s): Adie Viljoen, Anthony S. Wierzbicki
ATP Binding Cassette Transporter A1 (ABCA1) Associated Proteins:Potential Drug Targets in the Metabolic Syndrome and Atherosclerotic Disease?
Journal: Current Pharmaceutical Biotechnology
Volume: 13 Issue: 2 Year: 2012 Page: 319-330
Author(s): Christa Buechler, Sabrina Bauer
Signal Transduction Pathways Provide Opportunities to Enhance HDL and apoAI-Dependent Reverse Cholesterol Transport
Journal: Current Pharmaceutical Biotechnology
Volume: 13 Issue: 2 Year: 2012 Page: 352-364
Author(s): Vishwaroop Mulay, Peta Wood, Carles Rentero, Carlos Enrich, Thomas Grewal